Minimal change disease associated with anti-PD1 immunotherapy: a case report.

Bixia GaoNingjing LinSuxia WangYu Wang

Published in: BMC nephrology (2018)

The present case suggests an association between anti-PD1 therapeutic immune activation and the development of nephrotic syndrome. Given the increasing prevalence of oncologic immunotherapy, patients should be routinely monitored for kidney side effects associated with these agents.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
risk factors
peritoneal dialysis
rectal cancer
radical prostatectomy
patient reported